Future studies exploring the role of NAP1L1 in cardiac fibroblasts, as well as the crosstalk between cardiomyocytes and fibroblasts, could provide valuable insights into the broader impact of the NAP1L1 p.D349E variant in HCM and other forms of cardiomyopathy. The gene discussed is NAP1L1; the disease is cardiomyopathy.